Jonathan Wren to Prostatic Neoplasms
This is a "connection" page, showing publications Jonathan Wren has written about Prostatic Neoplasms.
Connection Strength
0.454
-
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer. 2019 May 06; 19(1):423.
Score: 0.132
-
Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1. J Clin Invest. 2016 Feb; 126(2):706-20.
Score: 0.104
-
Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer. Prostate. 2016 Jan; 76(1):97-113.
Score: 0.102
-
Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression. BMC Cancer. 2010 Dec 06; 10:672.
Score: 0.073
-
EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy. Oncogene. 2023 03; 42(12):861-868.
Score: 0.043